 Blueprint Medicines Corp NASDAQ:BPMC insider Debra Durso-Bumpus sold 2,500 shares of Blueprint Medicines stock in a transaction that occurred on Thursday, June 18th. The shares were sold at an average price of 75.18, for a total transaction of 187,950.00. Following the sale, the insider now owns 22,005 shares in the company, valued at approximately 1,654,335.90. ... 